NCT07164313 2026-04-14A Study of ZW251 in Participants With Advanced Solid TumorsZymeworks BC Inc.Phase 1 Recruiting100 enrolled
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 5 FDA
NCT06276491 2026-03-17Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsXencor, Inc.Phase 1 Recruiting282 enrolled